/XXII
XXII Stock - 22nd Century Group, Inc.
Consumer Defensive|TobaccoNASDAQ
$0.82-6.04%
$0.05 (-6.04%) • Jan 13
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10006.6%upside
Target: $82.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for XXII
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.81 – $0.82
TARGET (TP)$82.50
STOP LOSS$0.75
RISK/REWARD1:1232.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.00
52W High$225.40
52W Low$0.75
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.88M | $32.20M | $40.50M | $30.95M | $28.11M |
| Gross Profit | $-2,400,000 | $-8,696,000 | $1.85M | $1.49M | $1.44M |
| Gross Margin | -20.2% | -27.0% | 4.6% | 4.8% | 5.1% |
| Operating Income | $-13,950,000 | $-44,931,000 | $-33,635,000 | $-28,412,000 | $-19,183,000 |
| Net Income | $-15,164,000 | $-140,775,000 | $-59,801,000 | $-32,609,000 | $-19,711,000 |
| Net Margin | -127.7% | -437.1% | -147.7% | -105.4% | -70.1% |
| EPS | $-4001.31 | $-172108.45 | $-207642.36 | $-149582.57 | $-33.60 |
Company Overview
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
XXIIBeat Rate
39%
Last 18 quarters
Avg Surprise
-885.9%
EPS vs Estimate
Beats / Misses
7/10
1 met exactly
Latest EPS
$-1.06
Q4 2025
EPS Surprise History
Q1 24
-15970.2%
$-1427.03vs$-8.88
Q2 24
+67.4%
$-232.43vs$-713.51
Q3 24
+92.7%
$-48.65vs$-669.60
Q4 24
+88.7%
$-72.97vs$-648.00
Q1 25
+92.4%
$-48.96vs$-648.00
Q2 25
-71.8%
$-43.45vs$-25.29
Q3 25
-111.9%
$-13.16vs$-6.21
Q4 25
+93.7%
$-1.06vs$-16.79
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Mar 18, 2026 | — | — | — | — |
Q4 2025 | Nov 4, 2025 | $-16.79 | $-1.06 | +93.7% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $-6.21 | $-13.16 | -111.9% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-25.29 | $-43.45 | -71.8% | ✗ MISS |
Q1 2025 | Mar 20, 2025 | $-648.00 | $-48.96 | +92.4% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-648.00 | $-72.97 | +88.7% | ✓ BEAT |
Q3 2024 | Aug 13, 2024 | $-669.60 | $-48.65 | +92.7% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $-713.51 | $-232.43 | +67.4% | ✓ BEAT |
Q1 2024 | Mar 28, 2024 | $-8.88 | $-1427.03 | -15970.2% | ✗ MISS |
Q4 2023 | Nov 6, 2023 | $-1967.57 | $-1686.49 | +14.3% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-2270.27 | $-3027.03 | -33.3% | ✗ MISS |
Q2 2023 | May 9, 2023 | $-2269.14 | $-2593.30 | -14.3% | ✗ MISS |
Q1 2023 | Mar 9, 2023 | $-1944.97 | $-3889.95 | -100.0% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $-1620.81 | $-1944.97 | -20.0% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $-1620.81 | $-1944.97 | -20.0% | ✗ MISS |
Q2 2022 | May 5, 2022 | $-1944.97 | $-1620.81 | +16.7% | ✓ BEAT |
Q1 2022 | Mar 1, 2022 | $-1620.81 | $-1944.97 | -20.0% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | $-1296.65 | $-1944.97 | -50.0% | ✗ MISS |
Q3 2021 | Aug 5, 2021 | $-972.49 | $-972.49 | 0.0% | = MET |
Latest News
Loading news...
Frequently Asked Questions about XXII
What is XXII's current stock price?
22nd Century Group, Inc. (XXII) is currently trading at $0.82 per share. The stock has moved -6.04% today.
What is the analyst price target for XXII?
The average analyst price target for XXII is $82.50, based on 1 analyst.
What sector is 22nd Century Group, Inc. in?
22nd Century Group, Inc. operates in the Consumer Defensive sector, specifically within the Tobacco industry. The company is traded on the NASDAQ exchange.
What is XXII's market cap?
22nd Century Group, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does XXII pay dividends?
No, 22nd Century Group, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Consumer Defensive SectorFAMI
Farmmi, Inc.
$1.29
Mkt Cap: $0.0B
FEDU
Four Seasons Education (Cayman) Inc.
$12.07
Mkt Cap: $0.0B
GNLN
Greenlane Holdings, Inc.
$1.56
Mkt Cap: $0.0B
GSUN
Golden Sun Education Group Limited
$1.39
Mkt Cap: $0.0B
KAVL
Kaival Brands Innovations Group, Inc.
$0.03
Mkt Cap: $0.0B
MYND
Mynd.ai, Inc.
$0.46
Mkt Cap: $0.0B
ORIS
ORIENTAL RISE HOLDINGS Ltd
$1.47
Mkt Cap: $0.0B
SBEV
Splash Beverage Group, Inc.
$0.74
Mkt Cap: $0.0B
SNAX
Stryve Foods, Inc.
$0.01
Mkt Cap: $0.0B
TANH
Tantech Holdings Ltd
$0.99
Mkt Cap: $0.0B
Explore stocks similar to XXII for comparison